406 related articles for article (PubMed ID: 20883220)
21. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
[TBL] [Abstract][Full Text] [Related]
22. BMAL1-Downregulation Aggravates
Xie M; Tang Q; Nie J; Zhang C; Zhou X; Yu S; Sun J; Cheng X; Dong N; Hu Y; Chen L
Circ Res; 2020 Mar; 126(6):e15-e29. PubMed ID: 32078488
[TBL] [Abstract][Full Text] [Related]
23. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.
Chou HH; Yumoto H; Davey M; Takahashi Y; Miyamoto T; Gibson FC; Genco CA
Infect Immun; 2005 Sep; 73(9):5367-78. PubMed ID: 16113252
[TBL] [Abstract][Full Text] [Related]
24. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.
Hayashi C; Viereck J; Hua N; Phinikaridou A; Madrigal AG; Gibson FC; Hamilton JA; Genco CA
Atherosclerosis; 2011 Mar; 215(1):52-9. PubMed ID: 21251656
[TBL] [Abstract][Full Text] [Related]
25. A mouse model for pathogen-induced chronic inflammation at local and systemic sites.
Papadopoulos G; Kramer CD; Slocum CS; Weinberg EO; Hua N; Gudino CV; Hamilton JA; Genco CA
J Vis Exp; 2014 Aug; (90):e51556. PubMed ID: 25146644
[TBL] [Abstract][Full Text] [Related]
26. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
Miyamoto T; Yumoto H; Takahashi Y; Davey M; Gibson FC; Genco CA
Infect Immun; 2006 Feb; 74(2):1376-80. PubMed ID: 16428788
[TBL] [Abstract][Full Text] [Related]
27. Increases in IL-33 production by fimbriae and lipopeptide from Porphyromonas gingivalis in mouse bone marrow-derived dendritic cells via Toll-like receptor 2.
Tada H; Suzuki R; Nemoto E; Shimauchi H; Matsushita K; Takada H
Biomed Res; 2017; 38(3):189-195. PubMed ID: 28637954
[TBL] [Abstract][Full Text] [Related]
28. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.
Hayashi C; Papadopoulos G; Gudino CV; Weinberg EO; Barth KR; Madrigal AG; Chen Y; Ning H; LaValley M; Gibson FC; Hamilton JA; Genco CA
J Immunol; 2012 Oct; 189(7):3681-8. PubMed ID: 22956579
[TBL] [Abstract][Full Text] [Related]
29.
Bartnicka D; Gonzalez-Gonzalez M; Sykut J; Koziel J; Ciaston I; Adamowicz K; Bras G; Zawrotniak M; Karkowska-Kuleta J; Satala D; Kozik A; Zyla E; Gawron K; Lazarz-Bartyzel K; Chomyszyn-Gajewska M; Rapala-Kozik M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183255
[No Abstract] [Full Text] [Related]
30. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications.
Amar S; Wu SC; Madan M
J Immunol; 2009 Feb; 182(3):1584-92. PubMed ID: 19155507
[TBL] [Abstract][Full Text] [Related]
31. Porphyromonas gingivalis induces the production of interleukin-31 by human mast cells, resulting in dysfunction of the gingival epithelial barrier.
Tada H; Nishioka T; Takase A; Numazaki K; Bando K; Matsushita K
Cell Microbiol; 2019 Mar; 21(3):e12972. PubMed ID: 30423602
[TBL] [Abstract][Full Text] [Related]
32. Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm.
Wada K; Kamisaki Y
J Pharmacol Sci; 2010; 113(2):115-9. PubMed ID: 20501967
[TBL] [Abstract][Full Text] [Related]
33. Colocalization of Porphyromonas gingivalis with CD4+ T cells in periodontal disease.
Guyodo H; Meuric V; Le Pottier L; Martin B; Faili A; Pers JO; Bonnaure-Mallet M
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):175-83. PubMed ID: 22066676
[TBL] [Abstract][Full Text] [Related]
34. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
35. Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoE shl mice.
Miyauchi S; Maekawa T; Aoki Y; Miyazawa H; Tabeta K; Nakajima T; Yamazaki K
J Periodontal Res; 2012 Jun; 47(3):402-8. PubMed ID: 22097957
[TBL] [Abstract][Full Text] [Related]
36. Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis.
Sandal I; Karydis A; Luo J; Prislovsky A; Whittington KB; Rosloniec EF; Dong C; Novack DV; Mydel P; Zheng SG; Radic MZ; Brand DD
Arthritis Res Ther; 2016 Oct; 18(1):249. PubMed ID: 27784339
[TBL] [Abstract][Full Text] [Related]
37. Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen.
Miles B; Zakhary I; El-Awady A; Scisci E; Carrion J; O'Neill JC; Rawlings A; Stern JK; Susin C; Cutler CW
Infect Immun; 2014 Jan; 82(1):101-11. PubMed ID: 24126519
[TBL] [Abstract][Full Text] [Related]
38. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.
Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M
Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628
[TBL] [Abstract][Full Text] [Related]
39. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
40. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
Hajishengallis G; Sharma A; Russell MW; Genco RJ
Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
